The Changing Economic Value and Leverage of Arthroplasty Surgeons.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 35292340.
- Also identified by DOI 10.1016/j.arth.2022.03.035 and PMC identifier 9419662.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Moving THA off of the Inpatient Only (IPO) List for Center of Medicaid and Medicare Services (CMS) beneficiaries and the COVID-19 pandemic has caused a shift in delivery away from inpatient services and a decrease in demand. Medicare payments dramatically declined from 2019 to 2020. LOS decreases and shift to outpatient designations were accelerated by IPO list changes and COVID-19 issues. The percentage of SDD cases also increased. Other metrics favorable to decreased spending by CMS were increased discharge to home and decreased volume. These changes have a profound impact on surgeon-hospital relationships and surgeon compensation.
Medical subject headings
- Arthroplasty, Replacement, Hip
- COVID-19
- Surgeons
Anatomy
- hip